194 related articles for article (PubMed ID: 31002267)
1. Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs.
Logroscino G; Imbimbo BP; Lozupone M; Sardone R; Capozzo R; Battista P; Zecca C; Dibello V; Giannelli G; Bellomo A; Greco A; Daniele A; Seripa D; Panza F
Expert Opin Pharmacother; 2019 Jun; 20(9):1091-1107. PubMed ID: 31002267
[TBL] [Abstract][Full Text] [Related]
2. Frontotemporal dementia: from genetics to therapeutic approaches.
Buccellato FR; D'Anca M; Tartaglia GM; Del Fabbro M; Galimberti D
Expert Opin Investig Drugs; 2024 Jun; 33(6):561-573. PubMed ID: 38687620
[TBL] [Abstract][Full Text] [Related]
3. Disease-modifying therapies for tauopathies: agents in the pipeline.
Panza F; Imbimbo BP; Lozupone M; Greco A; Seripa D; Logroscino G; Daniele A; Colosimo C
Expert Rev Neurother; 2019 May; 19(5):397-408. PubMed ID: 30973276
[TBL] [Abstract][Full Text] [Related]
4. Therapy and clinical trials in frontotemporal dementia: past, present, and future.
Tsai RM; Boxer AL
J Neurochem; 2016 Aug; 138 Suppl 1(Suppl 1):211-21. PubMed ID: 27306957
[TBL] [Abstract][Full Text] [Related]
5. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
Seltman RE; Matthews BR
CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
[TBL] [Abstract][Full Text] [Related]
6. Advances in the treatment and management of frontotemporal dementia.
Benussi A; Borroni B
Expert Rev Neurother; 2023; 23(7):621-639. PubMed ID: 37357688
[TBL] [Abstract][Full Text] [Related]
7. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders.
Panza F; Lozupone M; Seripa D; Daniele A; Watling M; Giannelli G; Imbimbo BP
Nat Rev Neurol; 2020 Apr; 16(4):213-228. PubMed ID: 32203398
[TBL] [Abstract][Full Text] [Related]
8. New routes in frontotemporal dementia drug discovery.
De Conti L; Borroni B; Baralle M
Expert Opin Drug Discov; 2017 Jul; 12(7):659-671. PubMed ID: 28571480
[TBL] [Abstract][Full Text] [Related]
9. Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies.
Boxer AL; Boeve BF
Alzheimer Dis Assoc Disord; 2007; 21(4):S79-87. PubMed ID: 18090429
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biological phenotypes of frontotemporal dementia: Perspectives for disease modifying therapies.
Gazzina S; Manes MA; Padovani A; Borroni B
Eur J Pharmacol; 2017 Dec; 817():76-85. PubMed ID: 28579383
[TBL] [Abstract][Full Text] [Related]
11. New Approaches to the Treatment of Frontotemporal Dementia.
Neylan KD; Miller BL
Neurotherapeutics; 2023 Jul; 20(4):1055-1065. PubMed ID: 37157041
[TBL] [Abstract][Full Text] [Related]
12. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells.
Lines G; Casey JM; Preza E; Wray S
Mol Cell Neurosci; 2020 Dec; 109():103553. PubMed ID: 32956830
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of behavioral issues in frontotemporal dementia.
Manoochehri M; Huey ED
Curr Neurol Neurosci Rep; 2012 Oct; 12(5):528-36. PubMed ID: 22847063
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review.
Buoli M; Serati M; Caldiroli A; Galimberti D; Scarpini E; Altamura AC
J Geriatr Psychiatry Neurol; 2017 May; 30(3):162-169. PubMed ID: 28351199
[TBL] [Abstract][Full Text] [Related]
15. Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies.
Mackenzie IR; Neumann M
J Neurochem; 2016 Aug; 138 Suppl 1():54-70. PubMed ID: 27306735
[TBL] [Abstract][Full Text] [Related]
16. From FUS to Fibs: what's new in frontotemporal dementia?
Burrell JR; Hodges JR
J Alzheimers Dis; 2010; 21(2):349-60. PubMed ID: 20413882
[TBL] [Abstract][Full Text] [Related]
17.
Tsai RM; Bejanin A; Lesman-Segev O; LaJoie R; Visani A; Bourakova V; O'Neil JP; Janabi M; Baker S; Lee SE; Perry DC; Bajorek L; Karydas A; Spina S; Grinberg LT; Seeley WW; Ramos EM; Coppola G; Gorno-Tempini ML; Miller BL; Rosen HJ; Jagust W; Boxer AL; Rabinovici GD
Alzheimers Res Ther; 2019 Jan; 11(1):13. PubMed ID: 30704514
[TBL] [Abstract][Full Text] [Related]
18. An update on genetic frontotemporal dementia.
Greaves CV; Rohrer JD
J Neurol; 2019 Aug; 266(8):2075-2086. PubMed ID: 31119452
[TBL] [Abstract][Full Text] [Related]
19. Progress in frontotemporal dementia research.
Wang X; Shen Y; Chen W
Am J Alzheimers Dis Other Demen; 2013 Feb; 28(1):15-23. PubMed ID: 23221030
[TBL] [Abstract][Full Text] [Related]
20. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review.
Seelaar H; Rohrer JD; Pijnenburg YA; Fox NC; van Swieten JC
J Neurol Neurosurg Psychiatry; 2011 May; 82(5):476-86. PubMed ID: 20971753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
